WEBULL
News
ATRC
39.86
+1.55%
0.61
Weekly Report: what happened at ATRC last week (1124-1128)?
Weekly Report · 4d ago
Atricure Executives Make Significant Stock Sales
TipRanks · 11/27 02:12
AtriCure Director Sven Wehrwein Reports Disposal of Common Shares
Reuters · 11/26 21:43
AtriCure Chief Marketing & Strategy Officer Justin J. Noznesky Reports Sale of Common Shares
Reuters · 11/26 21:42
Atricure Director Makes a Significant Stock Sale!
TipRanks · 11/26 02:08
Wall Street Analysts Believe AtriCure (ATRC) Could Rally 36.3%: Here's is How to Trade
NASDAQ · 11/25 14:55
AtriCure Director Maggie Yuen Reports Sale of Common Shares
Reuters · 11/25 14:01
Weekly Report: what happened at ATRC last week (1117-1121)?
Weekly Report · 11/24 09:57
Weekly Report: what happened at ATRC last week (1110-1114)?
Weekly Report · 11/17 09:57
Weekly Report: what happened at ATRC last week (1103-1107)?
Weekly Report · 11/10 09:55
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings (Revised)
NASDAQ · 11/06 07:16
Weekly Report: what happened at ATRC last week (1027-1031)?
Weekly Report · 11/03 09:55
AtriCure’s Earnings Call Highlights Robust Growth and Innovation
TipRanks · 10/31 00:26
AtriCure Inc. Publishes Transcript of Q3 2025 Earnings Conference Call
Reuters · 10/30 20:07
AtriCure (ATRC) Q3 2025 Earnings Call Transcript
NASDAQ · 10/30 17:33
AtriCure Price Target Raised to $64.00/Share From $53.00 by Canaccord Genuity
Dow Jones · 10/30 13:38
AtriCure Is Maintained at Buy by Canaccord Genuity
Dow Jones · 10/30 13:37
Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $64
Benzinga · 10/30 13:27
Stifel Nicolaus Keeps Their Buy Rating on Atricure (ATRC)
TipRanks · 10/30 11:58
BTIG Sticks to Its Buy Rating for Atricure (ATRC)
TipRanks · 10/30 11:37
More
Webull provides a variety of real-time ATRC stock news. You can receive the latest news about Atricure through multiple platforms. This information may help you make smarter investment decisions.
About ATRC
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.